MedPath

â??A study of Amrutadi Tablet and Arbudahara Tablet in treatment of cancer of mouth induced by gutkha chewing

Phase 4
Conditions
Health Condition 1: null- Arbuda(Oral Cancer)
Registration Number
CTRI/2017/03/008127
Lead Sponsor
Govt Akhandanand Ayurved College and Hospital Ahmedabad and Maniben Ayurved Hospital Ahmedabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1 Patient diagnosed as squamous cell carcinoma (gutkha induced oral cancer) after histopathological report & being submitted for radiotherapy or chemotherapy or both.

2 Acute and chronic disorders

3 Cancer stages 0,I,II according to TNM criteria are included.

Exclusion Criteria

Metastasis

Patients suffering from severe systemic disorders and diseases like HIV, HbsAg etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvment in immune system, <br/ ><br>Improvement in pain, difficulty in swallowingTimepoint: 8 weeks
Secondary Outcome Measures
NameTimeMethod
Safety from other complicationsTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath